Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

A local treasure turns 40: Light Years celebrates four decades in Chapel Hill
In 1985, Light Years Jewelry first opened its doors to the Chapel Hill public, offering earrings, rings, trinkets and more. The shop is still there...
Wed Sep 17, 2025

Mediterranean Deli reopens on Franklin Street two years after fire: 'A gathering place'
Mediterranean Deli, a restaurant on 410 W. Franklin St., officially reopened Tuesday night after it closed following a roof fire in July 2023. Shortly after...
Tue Sep 16, 2025

Tyler Hansbrough, Marvin Williams, Other UNC Alumni Buy Professional Pickleball Franchise
Palm Beach will make history as the Palm Beach Royals become the city's first major pro sports franchise, joining Major League Pickleball as its 23rd...
Thu Sep 11, 2025

Tar Heels Take Part In Annual 9/11 Memorial Stair Climb
Hundreds of Tar Heels participated in the annual 9/11 Memorial Stair Climb, hosted by the UNC AROTC in Kenan Stadium on Thursday morning. Participants climbed...
Thu Sep 11, 2025